Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-MAPTRx in Patients With Mild Alzheimer's Disease

NCT03186989 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild Alzheimer's Disease

Interventions

DRUG: IONIS MAPTRx
OTHER: Placebo

Sponsor

Ionis Pharmaceuticals, Inc.